share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Casey Mark J

Novavax | 4: Statement of changes in beneficial ownership of securities

诺瓦瓦克斯医药 | 4：持股变动声明
SEC announcement ·  03/26 19:05
Moomoo AI 已提取核心信息
Mark J. Casey, EVP, CLO & Corporate Secretary of Novavax Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within Novavax, which could potentially influence the stock's performance.
Mark J. Casey, EVP, CLO & Corporate Secretary of Novavax Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within Novavax, which could potentially influence the stock's performance.
据报道，Novavax Inc. [NVAX] 执行副总裁、首席运营官兼公司秘书马克·凯西于2024年3月1日参与了一项涉及该公司股票的交易。公告中未披露交易的具体细节，包括行动类型、状态、所涉股份数量、股票性质、交易价格和交易后的持股情况。这些信息对于投资者了解Novavax内部活动至关重要，这可能会影响股票的表现。
据报道，Novavax Inc. [NVAX] 执行副总裁、首席运营官兼公司秘书马克·凯西于2024年3月1日参与了一项涉及该公司股票的交易。公告中未披露交易的具体细节，包括行动类型、状态、所涉股份数量、股票性质、交易价格和交易后的持股情况。这些信息对于投资者了解Novavax内部活动至关重要，这可能会影响股票的表现。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息